DrugCite
Search

LAMALINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lamaline Adverse Events Reported to the FDA Over Time

How are Lamaline adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lamaline, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lamaline is flagged as the suspect drug causing the adverse event.

Most Common Lamaline Adverse Events Reported to the FDA

What are the most common Lamaline adverse events reported to the FDA?

Cytolytic Hepatitis
18 (2.71%)
Fall
15 (2.26%)
Toxic Skin Eruption
15 (2.26%)
Asthenia
12 (1.81%)
Malaise
12 (1.81%)
Confusional State
11 (1.66%)
Gamma-glutamyltransferase Increased
11 (1.66%)
Loss Of Consciousness
10 (1.51%)
Disorientation
9 (1.36%)
Rash Maculo-papular
9 (1.36%)
Condition Aggravated
7 (1.06%)
Show More Show More
Urticaria
7 (1.06%)
Drug Interaction
6 (.9%)
Eosinophil Count Increased
6 (.9%)
Hyperthermia
6 (.9%)
Lymphadenopathy
6 (.9%)
Neutropenia
6 (.9%)
Pyrexia
6 (.9%)
Renal Failure Acute
6 (.9%)
Splenomegaly
6 (.9%)
Transaminases Increased
6 (.9%)
Vomiting
6 (.9%)
Abdominal Pain Upper
5 (.75%)
Abnormal Behaviour
5 (.75%)
Agitation
5 (.75%)
Agranulocytosis
5 (.75%)
Aspartate Aminotransferase Increase...
5 (.75%)
Dyspnoea
5 (.75%)
Hallucination, Visual
5 (.75%)
Hepatomegaly
5 (.75%)
Hunger
5 (.75%)
Hyperventilation
5 (.75%)
Oedema Peripheral
5 (.75%)
Pain
5 (.75%)
Rash Erythematous
5 (.75%)
White Blood Cell Count Increased
5 (.75%)
Abdominal Pain
4 (.6%)
Alanine Aminotransferase Increased
4 (.6%)
Anorexia
4 (.6%)
C-reactive Protein Increased
4 (.6%)
Cholestasis
4 (.6%)
Convulsion
4 (.6%)
Cytomegalovirus Antibody Positive
4 (.6%)
Discomfort
4 (.6%)
Erythema
4 (.6%)
Humerus Fracture
4 (.6%)
Injection Site Pruritus
4 (.6%)
Pustular Psoriasis
4 (.6%)
Somnolence
4 (.6%)
Stevens-johnson Syndrome
4 (.6%)
Wound
4 (.6%)
Aggression
3 (.45%)
Anxiety
3 (.45%)
Blood Alkaline Phosphatase Increase...
3 (.45%)
Catatonia
3 (.45%)
Cogwheel Rigidity
3 (.45%)
Disease Recurrence
3 (.45%)
Drug Rash With Eosinophilia And Sys...
3 (.45%)
Epstein-barr Virus Antibody Positiv...
3 (.45%)
Extrapyramidal Disorder
3 (.45%)
Faeces Discoloured
3 (.45%)
General Physical Health Deteriorati...
3 (.45%)
Genital Ulceration
3 (.45%)
Glomerulonephritis Membranous
3 (.45%)
Haematoma
3 (.45%)
Injection Site Urticaria
3 (.45%)
Lip Oedema
3 (.45%)
Lymphocyte Count Increased
3 (.45%)
Nausea
3 (.45%)
Orthostatic Hypotension
3 (.45%)
Oxygen Saturation Decreased
3 (.45%)
Pemphigus
3 (.45%)
Prurigo
3 (.45%)
Pruritus
3 (.45%)
Rash Macular
3 (.45%)
Thrombocytopenia
3 (.45%)
Thrombocytopenic Purpura
3 (.45%)
Venous Angioma Of Brain
3 (.45%)
Acute Respiratory Failure
2 (.3%)
Amnesia
2 (.3%)
Antinuclear Antibody Positive
2 (.3%)
Blood Bilirubin Increased
2 (.3%)
Blood Creatinine Increased
2 (.3%)
Cardiac Failure
2 (.3%)
Chest Pain
2 (.3%)
Chills
2 (.3%)
Coma Hepatic
2 (.3%)
Conjunctival Disorder
2 (.3%)
Constipation
2 (.3%)
Creatinine Renal Clearance Decrease...
2 (.3%)
Dehydration
2 (.3%)
Ecchymosis
2 (.3%)
Erythema Multiforme
2 (.3%)
Eye Pain
2 (.3%)
Face Oedema
2 (.3%)
Hallucination
2 (.3%)
Headache
2 (.3%)
Hepatic Encephalopathy
2 (.3%)
Hepatic Enzyme Increased
2 (.3%)
Hepatic Neoplasm
2 (.3%)
Hepatitis Cholestatic
2 (.3%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lamaline, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamaline is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lamaline

What are the most common Lamaline adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lamaline, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamaline is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lamaline According to Those Reporting Adverse Events

Why are people taking Lamaline, according to those reporting adverse events to the FDA?

Pain
42
Drug Use For Unknown Indication
33
Product Used For Unknown Indication
14
Sciatica
14
Rheumatoid Arthritis
13
Back Pain
12
Show More Show More
Arthralgia
7
Osteoarthritis
5
Toothache
5
Otitis Externa
4
Neuralgia
3
Bronchitis
3
Polyneuropathy
2
Constipation
2
Malaise
2
Lung Infection
2
Breast Cancer
2
Scar Pain
2
Migraine
2
Bone Pain
2
Pharyngolaryngeal Pain
1
Tonsillitis
1
Depression
1
Intervertebral Disc Protrusion
1
Self-medication
1
Bartholinitis
1
Coronary Artery Disease
1
Ill-defined Disorder
1
Fibromyalgia
1
Abdominal Cavity Drainage
1
Musculoskeletal Pain
1
Ankylosing Spondylitis
1
Analgesic Therapy
1
Herpes Zoster
1

Lamaline Case Reports

What Lamaline safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lamaline. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lamaline.